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The allogeneic effect, as initially described in guinea pigs (1-3) and more recently 
extended to inbred mice (4-6), demonstrates that the transfer of immunocompetent 
lymphoid cells to animals previously primed with a hapten-carrier conjugate, such as 
2,4-dinitrophenyl (DNP)1-keyhole limpet hemocyanin (K_LH), markedly enhances the 
antihapten antibody response to an appropriately timed secondary challenge with that 
hapten coupled to an unrelated carrier (for review, see reference 7). This phenomenon 
requires  the  initiation of an  active graft-vs.-host (GVH)  reaction in  the lymphoid 
tissue of the primed host, and reflects the direct interaction of the allogeneic donor 
thymus-derived (T)  cells with primed host bone marrow-derived (B)  lymphocytes, 
irrespective of the presence of host T  cells (5). Further, for the wide range of antigens 
heretofore employed, it has been shown to be essential that the host cell population 
be primed before the administration of allogeneic cells (1-4, 7). In our hands, numerous 
attempts with a variety of immunogenic molecules (or conjugates) have failed to show 
enhanced primary responses as a result of transfer of allogeneic cells (1-3), and these 
conditions frequently caused suppression of the primary response (4,  7). In contrast, 
Ordal and Grumet have recently described experiments in which the induction of a 
GVH reaction enabled genetic nonresponder mice to  develop primary antibody re- 
sponses,  of  the  IgG class,  to the synthetic polymer poly-L(Tyr,  Glu)-poly-D,•-Ala-- 
poly-L-Lys ([T, G]-A--L) (8). Their observations very clearly indicate the capacity of 
the  allogeneic effect, under  certain special circumstances,  to  influence antibody  re- 
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sponses in previously unprimed animals, and considered in the context of our repeated 
failures to observe such effects on primary antibody responses raise important ques- 
tions concerning the  nature of  the  conditions which permit the  expression of  the 
phenomenon in unprimed cell populations, 
The  present  studies  were  undertaken  to  investigate  the  influence of  the 
allogeneic effect on the primary response to  the nonimmunogen, DNP-D-GL, 
a  DNP  conjugate of  a  synthetic random copolymer of  D-glutamic acid  and 
l)-lysine. D-GL is a carrier molecule for which no specific helper T  cells exist (2, 
9), and conjugated as a DNP copolymer it normally induces a profound state 
of  hapten-specific tolerance in guinea pigs  (2)  and inbred mice  (10).  In the 
experiments described here, we have found that:  (a)  the allogeneic effect not 
only prevents the induction of tolerance by DNP-D-GL, but also promotes a 
striking primary anti-DNP antibody response, which  is primarily of the IgG 
class; (b) the allogeneic effect cannot be demonstrated to enhance primary re- 
sponses to immunogens such as DNP-ovalbumin (DNP-OVA) or DNP-KLH; 
and (c)  moreover, the removal of carrier-specific T  cells for KLH, presumably 
creating a  situation analogous to  that  for  D-GL,  does  not permit allogeneic 
lymphoid cells to enhance the primary response to DNP-KLH. 
Materials and Melhods 
Proteins  and  Hapten-Carrier  Conjugates.--Hen  OVA, recrystallized five times, was  ob- 
tained from Pentex Biochemical, Kankakee, Illinois. KLH was purchased from Pacific Bio- 
Marine Supply Co., Venice, Calif. D-GL was obtained from Pilot Chemicals, Inc., Watertown, 
Mass. The isomer had an average molecular weight of 50,000 and a ratio of G to L of 60:40. 
The following DNP conjugates were prepared as previously described (11, 12): DNPs-OVA 
and DNP14-KLH. The preparation  of DNP3~-D-GL has been described elsewhere (2). Sub- 
scripts refer to the average number of moles of DNP per mole of carrier for OVA and 9-GL 
and to the number of moles of DNP per 100,000 molecular weight units for KLH. 
Animals.--Mice of the inbred line A/J and (BALB/c X A/J)F1 hybrids (CAF1) were ob- 
tained from the Jackson Laboratory, Bar Harbor, Maine. All mice were used between 8 and 
12 wk of age. 
Depletion of T  Lyrnphocytes.--The  preparation  of anti-0 serum, determination  of anti-0 
serum cytotoxicity, and anti-0 treatment of spleen cells has been previously described (5). 
Cell  Transfers  and  Immunlzatlons.--Varying  numbers  of  semiallogeneic A/J  lymphoid 
cells, obtained as single-cell suspensions, prepared and washed in minimal essential medium 
(Eagle)  (MEM),  from spleens of normal donor mice were injected intravenously into non- 
immune CAF1 recipient mice. CAF1 mice which received no cell transfer served as controls. 
On the same day or at selected intervals after the cell transfer, groups of recipient and control 
mice were primarily immunized intraperitoneally  with one of several hapten-carrier  conju- 
gates. The mice were bled 7, 10, and 14 days after primary immunization and anti-DNP anti- 
body levels were determined as described below. In a number of studies, mice were sacrificed 
on day  10 and their  spleens removed for determination  of anti-DNP antibody-producing 
plaque-forming cells (PFC). 
Determination of AntI-DNP Antlbody-Producing PFC.--Single-cell suspensions of spleens 
from individual mice were separately prepared and washed in MEM.  Cells from the indi- 
vidual spleens were assayed for IgM and IgG anti-DNP antibody-producing PFC using a 
modification of the hemolytic plaque technique (13-15). Sheep erythrocytes  (SRBC) lightly DAVID P.  OSBORNE, JR.,  AND  DAVID H.  KATZ  993 
conjugated  with  2,4,6-trinitrobenzenesulfonic acid  (TNP)  were  used  as  indicators  (16). 
IgG PFC were developed using a rabbit antimouse immunoglobulin-facilitating serum. 
Measurement of Anti-DNP Antlbodies.--Serum anti-DNP antibody levels were determined 
by  a  modified  Farr  technique  (17, 18)  using  [3H]DNP-e-amino-N-caproic acid  (11). Em- 
ploying standard curves constructed for individual mouse strains in  a  manner previously 
described for inbred guinea pigs  (11), percentage of binding was converted into amount of 
anti-DNP antibody in micrograms per milliliter of serum. 
Statistical Analysis.--Serum  antibody levels and  PFC  per  spleen were logarithmically 
transformed and means and standard errors calculated. Group comparisons were made em- 
ploying Student's t test. In those mice in which no specific antigen binding could be detected 
in the serum, a value of 0.10 #g/ml was arbitrarily assigned to allow logarithmic transforma- 
tion of the data. 
RESULTS 
Effect of Allogeneic Cell Transfer on the Primary Response to DNP-D-GL.-- 
Groups of normal CAF1 mice were injected intravenously with 25 X  106 normal 
parental A/J spleen cells, and were then injected intraperitoneally with 100 #g 
of DNP-D-GL on the same day, 2 days later, or 5 days later. A control group 
of normal CAF1 mice which received no allogeneic cells was also injected with 
100 #g of DNP-D-GL. 
As shown in Fig. 1, the control mice, which did not receive allogeneic cells, 
made no detectable levels of anti-DNP antibody when injected with this dose 
of DNP-D-GL which has previously been shown to be tolerogenic in mice (10). 
In contrast, all mice receiving allogeneic cells developed weak anti-DNP anti- 
body responses after challenge with 100/zg of DNP-D-GL. The magnitude of the 
response obtained was dependent upon the time interval between administration 
of allogeneic  cells and challenge. Thus, the group injected with DNP-D-GL on 
the same day as cell  transfer made the highest antibody response, while an 
interval of 2 or 5 days between the administration of the allogeneic cells and 
challenge with DNP-D-GL resulted in significant, but lower, levels of anti-DNP 
antibody production.  Peak  antibody  production  occurred  on  day  10  after 
challenge in all groups. 
Effect  of  Varying  the  Dose of Allogeneic Cells on  the Primary Response to 
DNP-D-GL.--Since D-GL  is a  nonmetabolizable amino acid copolymer, sub- 
stantial levels of DNP-D-GL may remain in recipient mice after administration 
and subsequently bind significant quantities of circulating anti-DNP antibody. 
The following experiments were therefore designed to determine whether any 
discrepancy  may exist  between  the  actual  number  of  anti-DNP  antibody- 
producing cells (PFC) in the spleen and the quantity of their antibody product 
in the circulation. 
Groups of normal CAF1 mice were injected intravenously with varying numbers of normal 
parental A/J spleen cells  ranging from 10  to  100  X  108 cells per recipient. Normal CAF1 
mice which received no allogeneic  cells  served as controls. All groups were injected intra- 
peritoneally with 100/zg  of DNP-D-GL shortly after cell transfer. Serum anti-DNP antibody 
levels and IgM and IgG PFC in their spleens were assayed 10 days later. 994  ALLOGE!N~EIC EF~FECT  ON  PRIMARY  RESPONSES 
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FIG.  1,  Enhancement  of the primary response to DNP-])-GL in CAF1 recipients of pa- 
rental  A strain  lymphoid cells. Normal  CAF1 mice were injected intravenously  with 25  X 
106 A strain  spleen cells and challenged intraperitoneally  with 100/zg of DNP-D-GL either 
immediately after  cell transfer  or 2 or 5 days later.  Normal  CAF1 mice which received no 
allogeneic cell transfer and were challenged with 100 #g of DNP-D-GL served as controls. 7, 10, 
and 14 days after challenge the mice were bled and levels of serum anti-DNP antibody were 
determined. 
The results  are presented  in Table I  and  Fig.  2.  Unimmunized  CAF1 mice, 
not shown, possessed relatively high levels of background anti-DNP PFC. This 
high  background  activity  was  predominantly  directed  against  the  haptenic 
determinant on the SRBC, since PFC against unconjugated SRBC in the same 
mice were quite low (165 IgM and 30 IgG). No circulating antibody and only 
background levels of anti-DNP PFC were detected in control mice (group A). 
Allogeneic cell  recipients,  on  the  other hand,  manifested  augmented primary 
responses in terms of both PFC levels and quantities  of circulating anti-DNP 
antibody.  The magnitude  of the  effect was  clearly related  to  the  number  of 
allogeneic cells used.  The maximmn  IgM and IgG PFC  responses  on day 10 
were obtained with 50  X  106 parental  cells. However, the fact that somewhat 
higher  levels  of  circulating  anti-DNP  antibody  occurred  in  recipients  of 
100 X  10" cells suggests that the peak PFC responses of these mice may have DAVID P.  OSBORNE, JR.,  AND  DAVID II.  KATZ  995 
TABLE  I 
Effect of Varying the Dose of Allogeneic  Cells on the Primary Response  to DNP-D-GL 
Protocol*  AntI-DNP antibody response  (day 10):~ 
No. of A/J ceils  PFC/spleen 
transferred  Primary challenge  Serum  antibody  IgM  IgG 
Group 
~#ml 
A  None  1,940  3,956  0.1 
B  10  X  l0 s  1,611  3,853  2.6 
C  25  X  106  100 #g  3,637  8,402  5.1 
D  50  X  106  DNP-D-GL  6,609  19,091  6.3 
E  100  X  106  4,498  15,536  10.7 
* Groups  of normal CAF1  mice were injected intravenously with varying numbers, as 
indicated, of normal parental A/J spleen cells; CAF1 mice which received no allogeneic cells 
served as controls. All mice were injected intraperitoneally with 100 #g DNP-D-GL immedi- 
ately after cell transfer. Determinations of serum antibody and splenic PFC levels were made 
10 days after cell transfer and challenge. 
The data are expressed as geometric means of gioups of four mice. A  comparison of 
various groups yielded the following P  values. For IgM PFC: comparison of group A with 
group B, 0.80  >  P  >  0.70; group A with group C, 0.20  >  P  >  0.10; group A with group D, 
0.005  >  P  >  0.001; group A with group E, 0.025  >  P  >  0.02. For IgG PFC: group A with 
group B, 0.95  >  P  >  0.90; group A with group C, 0.01 >  P  >  0.005; group A with group D, 
0.001  >  P; group A with group E, 0.005  >  P  >  0.001. For serum anti-DNP antibody: com- 
parison of group A with groups B, C, D, and E yielded 0.001 >  P  in all cases. 
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FIG. 2.  Enhancement of the primary response to DNP-D-GL by the transfer of varying 
numbers of allogeneic  lymphoid cells.  Normal CAF1  mice were injected intravenously with 
varying numbers of parental A strain spleen cells and challenged intraperitoneally immediately 
thereafter with 100/zg of DNP-]~-GL.  Normal CAF1 mice which received no allogeneic  cell 
transfer and were challenged with 100 #g of DNP-D-GL served as controls. 10 days after cell 
transfer and challenge, levels of IgM and IgG anti-DNP splenic PFC were determined. 996  ALLOGENEIC  EFFECT  ON  PRIMARY  RESPONSES 
been  reached  at  an  earlier  time.  The  same  reasoning  probably  explains  the 
apparent  discrepancy  in  recipients  of  10  X  106  allogeneic  cells  which  mani- 
fested  no  increase  in  PFC  levels  while  their  circulating  anti-DNP  antibody 
responses were clearly higher than controls, 
Effect of Varying the Dose of DNP-D-GL.-- 
Groups of normal CAF1 mice either were injected intravenously with 25  X  106 normal 
parental A/J spleen cells or received no allogeneic cell transfer. Mice from each group were 
injected intraperitoneally with varying doses  (I,  10,  100, or 500/*g) of DNP-D-GL immedi- 
ately after cell transfer. Serum anti-DNP antibody levels and IgM and IgG PFC were de- 
termined 10 days later. 
The  results  are  summarized  in  Table  I[  and  illustrated  in  Fig.  3.  Control 
mice  (groups  A,  C,  E,  and  G)  displayed  no  detectable  circulating  anti-DNP 
antibodies  at  any  dose  of  DNP-D-GL  employed.  Such  mice  did  develop  low 
levels  of  IgM  and  IgG  anti-DNP  PFC  when  injected  with  1.0  or  10  tag  of 
DNP-D-GL  (groups  A  and  C),  whereas  the  number  of  PFC,  particularly  of 
TABLE  II 
Effect of Varying the Dose of DNP-~-GL on the Expression of the Allogeneic Effect 
Protocol*  Anti-DNP antibody response (day 10){ 
No. of A/J cells 
Group  transferred 
A  None 
B  25  X  10 ~ 
PF C/spleen  Serum 
Primary challenge  .............  antibody 
Ig.~  I g G 
#g  DNP-D-GL  lag/ml 
0.1  2,403  2,837  0.l 
5,636  8,710  0.7 
C  None  l0  3,471  3,734  0.1 
D  25  X  106  7,378  21,479  32.6 
E  None  100  544  806  0.1 
1"  25  X  106  5,229  44,137  33.0 
G  None  500  50  2,036  0.1 
H  25  X  10 ~  4,470  37,267  8.9 
* Groups of normal CAF1 mice were injected intravenously with 25 X  106 A/J spleen cells. 
CAF1 mice which received no cell transfer served as controls. All mice were injected with 
varying doses of DNP-D-GL  as indicated immediately after cell transfer. Determination of 
serum antibody and splenic PFC levels were made 10 days after cell transfer and challenge. 
:} The data are expressed as geometric means of groups of five mice. A comparison of various 
groups yielded the following P  values. For IgM PFC: comparison of group A with group B 
yielded 0.05  >  P  >  0.025; group C with group D, 0.10 >  P  >  0.05; group E with group  F, 
0.20  >  P  >  0.10; group G with group H, 0.025  >  P  >  0.02.  For IgG PFC: comparison  of 
group A with group B yielded 0.005  >  P  >  0.001; group C with group D, 0.001  >  P; group 
E with group F, 0.05  >  P  >  0.025; group G with group H, 0.001  >  P. For serum anti-DNP 
antibody: comparison of group A with group B, C with D, E with F, and G with H  yielded 
0.001  >  P  in all cases. DAVID P.  OSBORNE, JR.,  AND  DAVID H.  KATZ  997 
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Fro. 3.  Enhancement  of  the primary response  to  varying doses of DNP-D-GL  by the 
transfer of allogeneic lymphoid cells. Normal CAFI mice were injected intravenously with 
25 X  10 ~ parental A strain lymphoid cells (solid lines) while control CAF1 mice received no 
cell transfer (broken lines). Immediately after cell transfer, mice from both groups were chal- 
lenged intrapefitoneally with varying doses of DNP-D-GL.  10 days after cell transfer and 
challenge, both serum anti-DNP antibody levels and IgM and IgG anti-DNP splenic PFC 
were determined. 
IgM  class,  were  considerably diminished  below  background  in  control  mice 
injected with 100 or 500 #g of DNP-D-GL (groups E  and G). The higher doses, 
it should be noted, have been shown  to be tolerogenic (10).  In contrast,  allo- 
geneic cell recipients developed enhanced  primary anti-DNP  responses which 
were related in magnitude to the amount of DNP-D-GL administered up to the 
100/~g dose. The most striking effects were reflected in the anti-DNP PFC of 
the IgG class and the level of circulating antibodies. Increasing the dose to 500 
#g resulted in somewhat lower numbers of IgG PFC and considerably decreased 
quantities of circulating anti-DNP. These findings may well represent a balance 
between tolerance induction and immunity on  the one hand,  and binding and 
subsequent clearance of anti-DNP  antibodies by high levels of unmetabolized 
DNP-D-GL persisting 10 days after injection on the other. 
Effect of Allogeneic  Cell  Transfer  on  Primary Responses  to  DNP-D-GL  and 
DNP-O VA .- 
Groups of normal CAF1 mice were injected intravenously with 25 X  106 normal parental 
A/J spleen cells, while control CAF1 mice received no allogenelc cell transfer.  Immediately 
afte* cell transfer,  recipient and control mice were either primarily immunized  with 100 #g 
of DNP-OVA or injected with 100/zg of DNP-D-GL. 
9 998  ALLOGENEIC  EF~'ECT  ON  PRIMARY  RESPONSES 
The  results are summarized in Table III and  illustrated in Fig. 4.  Control 
mice (groups A  and C)  which received no allogeneic cells and were challenged 
with either DNP-D-GL or DNP-OVA produced no detectable serum anti-DNP 
antibodies. The levels of IgM and IgG anti-DNP PFC were somewhat, but not 
significantly, higher in mice injected with  DNP-D-GL. The  administration of 
allogeneic cells failed to increase the primary anti-DNP  antibody response to 
DNP-OVA as reflected by both serum antibody levels and IgM and IgG PFC 
(group  D).  In  marked  contrast,  the  mice which  received allogeneic cells and 
"FABLE III 
E~ect of Allogeneic Cell Transfer on Primary Anti-DNP Antibody Responses to 
DNP-D-GL and DNP-OVA 
Protocol* 
Group  No. of A/J cells  Primary challenge 
transferred 
Anti-DNP antibody response:~ 
PFC/spleen (day 10)  Serum antibody 
IgM  IgG  Day 7  Day 10 
lag/ml  #g/ml 
A  None  100/zg  4,352  7,069  0.1  0.1 
B  25  X  106  DNP-I)-GL  7,764  40,779  9.8  7.6 
C  None  100/zg  3,473  3,036  0.1  0.1 
D  25  >(  106  DNP-OVA  4,390  3,396  0.1  0.1 
* Groups of normal CAF1 mice were injected intravenously with 25 X  l0 G  normal parental 
A/J spleen cells. Control mice received no allogeneic cells. All mice were then injected intra- 
peritoneally  with either DNP-I)-GL or DNP-OVA immediately after cell transfer. Determina- 
tions of serum antibody and splenic PFC levels were made on the days indicated after cell 
transfer and challenge. 
:~ The data are expressed  as geometric  means  of groups of four mice.  A comparison  of 
various groups yielded the following P values. Comparing group A with group B : IgM PFC, 
0.50 >  P  >  0.40; IgG PFC, 0.025 >  P  >  0.02; serum antibody (day 7), P  >  0.001; serum 
antibody (day 10), P  >  0.001. There are no significant differences between group C and group 
D. 
were injected with DNP-B-GL  developed significantly higher responses as re- 
flected  by  considerably  increased  levels  of  IgG  anti-DNP  PFC  and  serum 
anti-DNP antibodies. There was no appreciable change in the number of IgM 
PFC. 
Effect  of Depletion  of Host  T  Lymphocytes  on  the Capacity  of the Allogeneic 
Effect to Enhance Primary Anti-DNP Antibody Responses.--The failure to obtain 
an  allogeneic effect on primary responses to DNP-OVA,  as shown  in the pre- 
ceding experiment, whereas such  an  effect can  be reproducibly obtained with 
the nonimmunogen, DNP-D-GL, raises several interesting questions concerning 
the  nature  of  the  phenomenon.  A  valid  consideration  is  that  the  molecular 
structure  of  the  carrier  employed  is  critical, the  phenomenon  being  favored 
perhaps by more complex molecules. However, similar experiments (not shown) DAVID  P.  OSBORNE,  JR.~  AND  DAVID H.  KATZ  999 
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FIG. 4.  The effect of allogeneic cell transfer on the primary responses to DNP-D-GL and 
DNP-OVA. Normal CAF1 mice were injected intravenously with 25 )< 106 parental A strain 
spleen cells and then challenged intraperitoneally  with either 100/zg of DNP-I)-GL or DNP- 
OVA. Control CAF1 mice, which received no allogeneic cell transfer,  were challenged with 
either 100/zg of DNP-D-GL or 100 #g of DNP-OVA.  10 days after cell transfer and challenge, 
both serum anti-DNP antibody levels and IgM and IgG anti-DNP PFC were determined. 
using KLH  as a  more complex carrier than  OVA have failed to support  this 
notion in  that no  enhancement  of primary responses to DNP-KLH  were  ob- 
served as a result of allogeneic lymphoid cell transfer. Another possible explana- 
tion for these differences may be that the absence of carrier-specific T  lympho- 
cytes, which  is true  in  the case of D-GL, is crucial for expression of a  direct 
influence of allogeneic T  cells upon  the DNP-specific B  cell precursors in the 
unprimed host lymphocyte population. This possibility was tested in a  double 
adoptive  transfer  model  in  which  host  spleen  cells were  depleted of  their  T 
lymphocyte component by treatment with anti-0 serum and complement. 
Spleen cells from normal CAF1 donor mice were treated in vitro with either normal mouse 
serum  (NMS)  and complement  or anti-0 serum and complement.  These cells were mixed in 
vitro (on ice) with parental A/J spleen cells (ratio of 3 X  106 parental cells to 20 X  106 CAF1 
cells) and appropriate amounts of either DNP-D-GL  or DNP-KLH and were then injected 
intravenously into irradiated  (550 R)  CAF1 recipients.  Control groups  of recipient mice 
were injected with NMS and complement-treated CAF1 donor cells plus antigen without 
allogeneic lymphoid ceils. All recipients  were bled and tested for splenic anti-DNP PFC 10 
days after cell transfer and challenge. 
The results are summarized in Table IV and illustrated in Fig. 5. As shown 
in  Table  IV,  the  administration  of  allogeneic cells markedly diminished  the 
proliferative response of transferred syngeneic cells in irradiated CAFI hosts as 
reflected by the number of spleen cells recovered on day 10.  (Compare groups 
B, C, E, and F  with groups A  and D.)  The data, therefore, can be validly ex- 
pressed only in terms of PFC per l06 recovered cells. Control CAF1 recipients 
of NMS plus complement-treated cells alone failed to develop primary responses 1000  ALLOGEN'EIC  EFFECT  ON  PRIMARY  RESPONSES 
TABLE IV 
Effect of Depletion of Host T Lymphocytes on the Capacity of the Allogeneic Effect 
to Enhance Primary Anti-DNP Antibody Responses 
Protocol*  Anti-DNP antibody 
Spleen cells  response (day 10)~ 
Primary challenge  recovered per 
Group  Treatment of host  No. of A/J cells  recipient  IgM  IgG 
spleen cells  transferred 
A 
B 
C 
D 
E 
F 
(>(106)  PFC/IO 6  PFC/IO~ 
cells  cells 
NMS +  C'  None  67.4  28.7  23.5 
NMS  +  C'  3  X  106  100 #g  31.0  29.0  69.5 
Anti-0 +  C'  3  X  106  DNP-D-GL  20.1  43.6  111.8 
NMS +  C'  None  78.0  42.1  42.9 
NMS +  C'  3  >(  10 6  100 #g  28.4  31.4  39.5 
Anti-0 +  C'  3  X  106  DNP-KLH  20.0  13.7  14.8 
* Spleen cell suspensions from normal CAF1 mice, treated with either NMS and comple- 
ment or anti-0 serum and complement, were injected intravenously into 550 R-irradiated 
syngeneic recipients, with or without parental A/J spleen cells, and with either  100 #g of 
DNP-D-GL or 100 #g of DNP-KLH. Determination of splenic PFC levels were made 10 days 
after cell transfer and challenge. 
The data are expressed as geometric means of groups of five mice. A comparison of 
various groups yielded the following P  values. For IgM PFC: comparison of group A with 
group B yielded 0.98 >  P  >  0.975; group A with group C, 0.30 >  P  >  0.20; group D with 
group E, 0.40 >  P  >  0.30; group D  with group F, 0.01 >  P  >  0.005, For IgG PFC: com- 
parison of group A with group B yielded 0.01 >  P  >  0.005; group A with group C, 0.05 > 
P  >  0.025; group D with group E, 0.80 >  P  >  0.70; group D with group F, 0.005 >  P  > 
0.001. 
to DNP-D-GL (group A)  and only barely appreciable increases in anti-DNP 
PFC levels with DNP-KLH (group D).  The  administration of parental allo- 
geneic lymphoid cells  resulted  in significant increases in  primary anti-DNP 
PFC  responses,  particularly  of  the  IgG  class,  of  mice  challenged  with 
DNP-D-GL. This was true irrespective of whether the original donor inoculum 
of CAFa cells had been treated with NMS and complement (group B) or anti-0 
serum  plus  complement  (group  D).  In  contrast,  comparable  recipient  mice 
which were challenged with DNP-KLH (groups E  and F) failed to display any 
increase in anti-DNP PFC. In fact,  the PFC levels obtained in  these groups, 
particularly in the case of recipients of anti-0 serum-treated CAF1 donor cells, 
were  lower  than  those  manifested by control mice in group D,  probably re- 
flecting the loss of KLH-specific T  lymphocytes. 
Capacity  of the Allogeneic Effect  to  Enhance  the Primary  Responses  to  Both 
DNP-D-GL and DNP-L-GL.--The  failure of the allogeneic effect to induce an 
enhanced primary response to DNP-KLH after depletion of host T lymphocytes 
argues strongly that it is not merely the absence of carrier-specific T  lympho- 
cytes which enables this effect to be shown so well with DNP-D-GL, but rather DAVID  P.  OSBORNE,  JR.~  AND  DAVID  H.  KATZ  1001 
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FIG. 5.  The  effect  of allogeneic  cell  transfer on  the primary responses  to  DNP-o-GL 
and DNP-KLH after depletion of T  lymphocytes. Spleen cells from  normal donors  were 
treated in vitro with either NMS and complement  or anti-0 serum and complement.  These 
cells were mixed in vitro with parental A strain spleen cells (a ratio of 3 X  106 A cells to 20 
X  10 ~ CAF1 cells) and either DNP-D-GL or DNP-KLH and were then injected intravenously 
into irradiated (550 R)  CAF1 recipients.  10 days later spleens were removed  and levels of 
IgM and IgG PFC determined. 
some intrinsic feature of the carrier molecule itself. To test this hypothesis, the 
following study was  performed  comparing  the  capacity of allogeneic cells to 
enhance the primary response to both DNP-D-GL and DNP-L-GL. DNP-L-GL 
is a  DNP  conjugate of the random copolymer of L-glutamic acid and L-lysine. 
Whereas  DNP-D-GL  is  a  nonmetabolizable  molecule  which  easily  induces 
tolerance over a  wide dose range, DNP-L-GL is a  readily metabolizable mole- 
cule which,  in inbred mice, is "nonimmunogenic" at all doses presumably be- 
cause  of  a  lack of carrier-specific helper  T  lymphocytes,  and  which  induces 
tolerance only in a  very restricted dose range (Katz, D. H., T. Hamaoka, and 
B. Benacerraf, unpublished observations). 
Normal CAF1 mice were injected intravenously with 50 X  l0 s parental A/J spleen cells, 
while control CAF1 mice received no allogeneic cell transfer.  Immediately after cell transfer, 
control and recipient mice were injected intraperitoneally with either 100 #g of DNP-D-GL 
or 100/zg of DNP-L-GL. All mice were killed I0 days later for determinations of splenic anti- 
DNP PFC, 
The  results  are shown  in  Table  V.  Control  mice  (groups A  and  C)  which 
received  no  allogeneic cells  and  were  challenged  with  either  DNP-D-GL  or 
DNP-r,-GL displayed only background levels of both IgM and IgG anti-DNP 1002  ALLOGENEIC  EFFECT  ON  PRIMARY RESPONSES 
TABLE  V 
Capacity of the Allogeneie Effect to Enhance the Primary Responses to DNP-D-GL 
and DNP-~-GL 
Protocol*  Anti-DNP antibody response  (day 10)~ 
No. A/J ceils  Primary challenge  IgM  IgG  Group  transferred 
PFC/spleen  PFC/spleen 
A  None  100 p,g  1,263  2,326 
B  50  X  l0 s  DNP-D-GL  5,910  12,254 
C  None  100 #g  2,030  1,332 
D  50  X  106  DNP-L-GL  3,143  4,789 
* Normal CAFI mice were injected intarvenously with 50 X  106 parental A/J spleen cells. 
CAF1 mice which received no cell transfer served as controls, Mice from both groups were 
injected with either 100 #g of DNP-D-GL or 100/zg of DNP-L-GL shortly after cell  transfer. 
Determination of splenic PFC levels were made 10 days after cell transfer and challenge. 
:~ The data are expressed as geometric means of groups of five mice. A comparison of various 
groups yielded the following P  values. For IgM PFC: comparison of group A with group B 
yielded 0.01 >  P  >  0.005; group C with group D, 0.20  >  P  >  0.10. For IgG PFC: compari- 
son of group A with group B yielded 0.001 >  P; group C with group D, 0.005  >  P  >  0.001. 
PFC.  On  the  other hand,  recipients of  allogeneic lymphoid cells manifested 
increased numbers of splenic PFC when challenged with either DNP-D-GL or 
DNP-L-GL. As seen previously, this enhancement of the primary response was 
particularly marked in PFC of the IgG antibody class. The fact that the magni- 
tude of the  response was  greater after challenge with  DNP-D-GL than with 
DNP-L-GL most probably reflects the more rapid metabolism of DNP-5-GL 
and its subsequent removal from the system. 
DISCUSSION 
Since the demonstration  that cooperation  between  T  and B  lymphocytes  is 
required  for antibody  production  to the vast majority  of antigens  (19-21), 
considerable  attention  has  been  focused  on  elucidating  the nature  of these 
cellular interactions and the details of the control mechanisms  implicit in them 
(for review, see reference 22). The allogeneic effect phenomenon has served as 
one highly useful model for investigating the regulatory influences of T lympho- 
cytes on  B  cell responses  to  antigen  (reviewed in  reference 7).  Indeed,  this 
phenomenon has provided a forceful argument for the concept of the expression 
of T  cell function via release of nonspecific mediators active in the process of 
B cell triggering by antigen (7, 22). 
In our previous studies in this system, it was quite clear that the responding 
B cell population must be primed before the allogeneic cell transfer in order for 
the phenomenon to occur (1-4). Attempts to demonstrate enhanced primary 
responses to typical antigens such as DNP-OVA or DNP-KLH not only failed, DAVID  P.  OSBORNE,  JR.,  AND  DAVID  tI.  KATZ  1003 
but frequently resulted in marked suppression of the primary response. In the 
present study, we have altered our previous approaches to investigating the 
influence of the allogeneic effect on primary antibody responses by utilizing the 
nonimmunogen, DNP-D-GL. As pointed out in the introduction, this conjugate 
has several unique features. Particularly important is the capacity of DNP-D- 
GL to induce a profound state of DNP-specific tolerance in both normal and 
DNP-primed animals (2, 10). However, in the presence of the allogeneic effect, 
this same molecule provides a positive triggering signal (2, 4). This represents, 
perhaps,  the most relevant model of the direct influence of activated T  cells 
on  B  lymphocytes. Thus,  B  cells  exposed  to  DNP-D-GL  in  the  absence  of 
activated T cells and/or their product(s) are rapidly rendered tolerant, whereas 
exposure to  DNP-D-GL  in  the  presence of T  cell function results  in  DNP- 
specific immunity. These contrasting results, clearly determined by the presence 
or absence of T cell activity, led us to consider that the activated T cells and/or 
their product(s) which play such a crucial role in the triggering of primed B cells 
exposed  to  DNP-D-GL,  may influence  as  well  the  response  of unprimed  B 
lymphocytes to this normally tolerogenic compound. 
Indeed, the observations reported here illustrate that  the presence of non- 
specific T cell function generated during the allogenei  c effect alters the ultimate 
response of unprimed B lymphocytes to DNP-I)-GL. Thus, normal CAF1 mice, 
which ordinarily fail to develop antibody responses to this compound, mani- 
fested significant primary anti-DNP  responses when DNP-D-GL was  admin- 
istered  in  conjunction  with  parental  A/J  donor  spleen  cells.  The  primary 
responses obtained in this way were particularly notable in that they were pre- 
dominantly of the IgG antibody class.  The capacity to induce such an effect, 
as shown here, is determined by the concomitant influences exerted by variables 
such as timing of the allogeneic cell transfer in relation to primary challenge, 
number of allogeneic cells employed, and the dose of DNP-D-GL administered. 
However, in contrast to relatively greater restrictions in this regard insofar as 
the allogeneic effect on secondary antibody responses in mice (4), these variables 
operate over a considerably wider range to permit expression of the phenomenon 
in  primary responses  to  DNP-D-GL.  Hence,  the  effect was  observed in  the 
present studies when allogeneic cells  ranging in  number from  107  to  108 per 
recipient were administered over intervals from 5 days before to simultaneously 
with primary inoculation of various doses of DNP-D-GL. The peak effect ap- 
peared to occur when 50 X  106 parental spleen cells were administered on the 
same day as primary challenge with  100/zg of DNP-I)-GL. Moreover, it has 
been essential to examine antibody production at the cellular level, i.e. anti- 
DNP splenic PFC, as well as the level of serum antibody in order to appreciate 
the  absolute magnitude of the phenomenon. This is necessitated by the fact 
that DNP-D-GL, itself nonmetabolizable, tends to remain in the system with 
the capacity to bind  to and result in  the subsequent clearance of circulating 
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These findings emphatically demonstrate that what is normally a signal for 
DNP-specific tolerance can be converted to a signal for DNP-specific immunity 
in the appropriate atmosphere of T cell activation and possible mediator release. 
The fact that the antibody response obtained under such circumstances is pre- 
dominantly of the IgG class underscores the importance of T  cell regulatory 
influences on the class shift from IgM to IgG in humoral immune responses 
(22, 23). The latter point was also nicely illustrated in the recent experiments 
of Ordal and Grumet (8)  in genetic nonresponder mice which are believed to 
lack functional T  cells with specificity for (T, G)-A--L (24).  In their system, 
genetic nonresponders normally develop primary antibody responses to aqueous 
(T, G)-A--L which are restricted to the IgM antibody class. However, induction 
of an appropriately timed GVH reaction permitted such nonresponder mice to 
develop primary responses to (T, G)-A--L of both IgM and IgG antibody classes 
(8). In this sense, our present results fully corroborate their important observa- 
tion. 
An obvious point of similarity between the present studies and those of Ordal 
and Grumet cited above (8) is the fact that in both systems the allogeneic effect 
exerts demonstrable influences on primary antibody responses to substances for 
which, in the animals employed, no helper T cell function exists. More recently, 
a similar phenomenon of enhanced antibody production has been found in pri- 
mary  responses  to  the  thymus-independent  type  III  pneumococcal  poly- 
saccharide  (Sin)  in  mice  undergoing  a  GVH  reaction.  2 On  the  other  hand, 
repeated  attempts  to  obtain  any  appreciable  allogeneic  effect  on  primary 
antibody responses to immunogenic conjugates such as DNP-OVA  or DNP- 
KLH have failed in the present experiments as well as in studies reported pre- 
viously (1-3,  7).  Taken collectively, these various findings indicate that the 
capacity of the allogeneic effect to exert any enhancing influence on the re- 
sponses of unprimed B lymphocytes to specific molecules is largely determined 
by the nature of the molecule employed. 
As  an  explanation for  the  role  of molecular  structure,  one may consider 
several possible factors. First, since all of the aforementioned molecules have 
been  either  inherently  or  consequently operating in  the  absence  of  specific 
functional T  cells,  it is conceivable that the very presence of antigen-specific 
T cell function may interfere with the expression of nonspecific T cell participa- 
tion (allogeneic effect). This concept is frankly difficult to reconcile with the 
many observations made in  studies of the  allogeneic  effect in  secondary re- 
sponses (7) unless it is accepted that fundamental differences between primed 
vs. unprimed B lymphocytes are critical in this regard. Nonetheless, based on 
this reasoning, we examined the possibility by using adoptively transferred un- 
primed spleen cell populations which had been depleted of the T  lymphocyte 
2 Byfield,  P.,  G.  H.  Christie,  and J.  G.  Howard.  1972.  Alternative potentiating  and in- 
hibitory  effects  of  a  GVH  reaction  on  antibody  formation  against  a  thymus-independent 
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component  by  treatment  with  anti-0  serum  plus  complement.  Under  these 
circumstances, it was  still possible  to obtain an allogeneic effect on primary 
antibody responses to DNP-D-GL. Conversely, such T  cell-depleted spleen cell 
populations failed to develop primary responses to DNP-KLH irrespective of 
whether or not allogeneic cells were concomitantly administered. This observa- 
tion argues against  the possibility that  the presence of antigen-specific func- 
tional T  cells,  or, for that matter, any T  cells results in an interference in the 
expression of the allogeneic effect on the primary response. 
A second possibility to explain the observations concerns the inherent molec- 
ular structure of the substances employed. The common feature of DNP-D-GL, 
DNP-L-GL, (T,G)-A--L, and Sm is their more or less repetitive determinant 
structure. This type of determinant arrangement appears to favor, under cer- 
tain circumstances, the transduction of immunogenic signals to at least some B 
lymphocytes in the absence of T cell function (22). The antibody responses ob- 
tained  with  these  and  other  "thymus-independent"  antigens  are,  however, 
restricted to the IgM class which indicates that despite their capacity to trigger 
specific B cell precursors of this class, the switch to IgG requires the additional 
participation  of T  lymphocytes regardless  of the  molecular structure of the 
antigen.  The fact  that  the  presence of  T  cell  function  as  provided  by  the 
allogeneic effect permits the development of IgG antibody responses to DNP- 
D-GL or DNP-L-GL as shown herein and to (T, G)-A--L in nonresponder mice 
(8) demonstrates not only the critical role of T  cells in the IgM to IgG switch 
but also that these molecules are not in themselves prohibitive to a triggering 
event in IgG precursor cells.  Clearly, we have no definitive data as to why the 
unique structure of certain molecules permits triggering of IgM antibody re- 
sponses in the absence of T  cell participation. Nor do we know why these very 
same  types of molecules elicit enhanced primary antibody responses,  of the 
IgG  class,  in  the  presence of  the  allogeneic  effect whereas  typical multide- 
terminant molecules such  as DNP-KLH or DNP-OVA  do not. What  seems 
clear,  however,  is  that  the  molecular  features  which  dictate  thymus  inde- 
pendence are also essential for expression of the allogeneic effect on antibody 
responses in unprimed cell populations. 
A final consideration must be given to the different conditions under which 
allogeneic lymphocytes are able to affect unprimed and primed B cell popula- 
tions. It is clear that very critical differences must exist since primed B lympho- 
cytes  have  been  amply  shown  to  manifest  enhanced  responsiveness  to  all 
antigens as a result of the allogeneic effect. The responsiveness of such lympho- 
cytes can also be suppressed under the appropriate conditions of the allogeneic 
effect (4,  7). In contrast, unprimed B lymphocytes, although often suppressed 
by the induction of a  GVH reaction, are readily susceptible to immediate en- 
hancing  effects of this  phenomenon,  only with  respect to a  selected class of 
antigen molecules. Thus, insofar as the triggering signal for differentiation into 
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occasioned by interactions with antigen and T  lymphocytes appear to impart 
qualitative differences in the reactivities of such cells not only to subsequent 
exposure to antigen but to T cell influences as well. By this reasoning unprimed 
B lymphocytes may possess a more restricted threshold of reactivity which, for 
typical antigens, places great limitations on their capacity to be influenced by 
T  cell  activity during early stages of immune induction. On the other hand, 
structurally unique molecules as exemplified in  these studies by DNP-D-GL 
may result in a  type of cooperative receptor-binding event which drastically 
changes the reactivity threshold of specific B lymphocytes and, irrespective of 
the state of priming, results in a higher level of susceptibility of such cells to 
the enhancing influences of activated T  cells. Whether the unique antigenic 
structural requirements for expression of the allogeneic  effect in vivo on un- 
primed vs. primed cell  populations can be  explained simply on the basis  of 
maturation  of  a  specific  primed  B  lymphocyte population  to  progressively 
higher average receptor affinity or, rather, by certain undefined consequences of 
the allogeneic cell interactions merit further investigation, 
Although  no  allogeneic  effect has  been  obtained  in  terms  of  immediate 
antibody production to typical antigens in these studies, it is not inconceivable 
and is perhaps quite likdy that some enhancing influences on priming and sub- 
sequent expression of specific memory may occur in such circumstances. Studies 
designed to delineate this possibility and the predominant host cell(s)  affected, 
i.e. B or T  lymphocyte (or both), are under way. 
SIJMMARY 
The allogeneic effect has been shown to replace the requirement for carrier- 
specific  helper  thymus-derived  (T)  lymphocytes  in  secondary  antihapten 
antibody responses  in  guinea  pigs  or  mice.  Attempts  to  enhance  primary 
antibody  responses  to  either  2,4-dinitrophenyl  (DNP)-keyhole  limpet 
hemocyanin (KLH) or DNP-ovalbumin (OVA)  by the  allogeneic  effect have 
failed,  and  frequently  result  in  suppression.  However,  the  present  studies 
have demonstrated a clear allogeneic effect on primary anti-DNP responses to a 
DNP-conjugate of the copolymer of D-glutamic acid and D-lysine, DNP-D-GL. 
This  compound,  for which  no  carrier-specific  helper  T  cells  exist,  normally 
induces  a  state  of DNP-specific  tolerance in  the doses employed. However, 
normal (BALB/c X  A/J)F1 recipients developed primary anti-DNP antibody 
responses, and of the IgG class, when DNP-D-GL was administered shortly after 
the transfer of allogeneic parental A strain lymphoid cells. To test the possibility 
that the presence of KLH-specific T  lymphocytes might inhibit the expression 
of the allogeneic  effect on the primary response to DNP-KLH, studies were 
undertaken using  T  cell-depleted  spleen  cells.  In  this  model,  the  allogeneic 
effect again enhanced the primary response to DNP-D-GL, but still failed to 
enhance the primary response to DNP-KLH. These studies indicate that the 
structure of the molecule employed and its specific interaction with the bone DAVID P.  OSBORNE, JR.,  AND  DAVID tI.  KATZ  1007 
marrow-derived (B)  cell membrane  may be critical in the capacity of primed 
and unprimed B  cells to be influenced by the allogeneic effect. 
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